Istituto Neurologico Mediterraneo Neuromed

What Istituto Neurologico Mediterraneo Neuromed does

Istituto Neurologico Mediterraneo Neuromed (IRCCS Neuromed S.p.A.) is a privately held Italian scientific research and care hospital headquartered in Pozzilli, Molise, with a secondary research campus — the Neurobiotech hub — in Caserta. Founded in 1976 and formally recognized as an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) by the Italian Ministry of Health in 1983, the institution operates as a specialized neuroscience center of national relevance, delivering clinical services in neurology, neurosurgery, neurorehabilitation, stroke care, and cardiology alongside an active translational research program. Core service lines include advanced diagnostic imaging (3T MRI, PET-CT for Alzheimer's and Parkinson's, nuclear medicine), a Stroke Unit, oncology and ophthalmology multidisciplinary centers, a rare neurological diseases center, telemedicine, and a suite of 40+ outpatient specialty clinics. The research portfolio is anchored by the Moli-sani longitudinal epidemiological study tracking approximately 25,000 adults for over 20 years and by Neurobiotech's programs in Big Data-driven precision medicine, neurocybernetics, and epigenetics.

The institute generates revenue through four streams: reimbursement from the Italian National Health Service (SSN) under ticket-based co-pay, private professional fees (libera professione) for patients opting out of public coverage, competitive research grants (Ministry of Health, PNRR, EU programs, foundations such as Veronesi and Telethon), and charitable contributions including the Italian 5x1000 taxpayer designation. It sells through referral-based patient acquisition within the SSN, supplemented by online and WhatsApp booking, and pursues partnerships with 20+ academic and clinical institutions including Sapienza, Tor Vergata, Milan, Lund, and Washington University in St. Louis. Quality is independently validated: ranked sixth nationally for brain tumor craniotomies (PNE 2025, first in Centro-Sud), 13-20 researchers on Stanford's World's Top 2% Scientists list, and recipient of the Bollini Rosa ONDA 2025 award. Ownership rests with the holding I.SVI.M S.p.A., with Prof. Giovanni De Gaetano serving as legal representative.

Name

Istituto Neurologico Mediterraneo Neuromed

Legal name

Istituto Neurologico Mediterraneo Neuromed S.p.A.

Website

https://neuromed.it

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

501–1,000 employees

Short description

IRCCS Neuromed is a privately held Italian neuroscience research hospital in Pozzilli providing neurology, neurosurgery, neurorehabilitation, and advanced diagnostics, anchored by the Moli-sani 25,000-adult epidemiological study and the Neurobiotech precision-medicine research hub.

Ownership category

akta.pro rank

Product category

Neurological Hospital and Research Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Neurology & Neurosurgical Specialty Hospitals (HLAFAHAD)

akta.pro secondary industries

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA), Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)

Keywords

• Neurological hospital services
• Neurosurgery clinical care
• Neuroscience research
• Precision medicine research
• Neurorehabilitation services

Headquarters

HQ city

Pozzilli

HQ country

Italy

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Others

Revenue model

1. National Health Service (SSN) Reimbursement: Healthcare services delivered under the Italian National Health Service with ticket-based patient co-pays and full public coverage for covered services
2. Private Pay Services: Libera professione (private professional) services with institutional tariff schedules for patients choosing private care outside SSN coverage
3. Research Grants and Funding: Government and institutional research funding including Ministry of Health grants, European research projects (PNRR), and competitive research financing
4. Donations and 5x1000: Charitable donations and Italian taxpayer contributions through the 5x1000 mechanism supporting research activities

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

IRCCS Neuromed is a private scientific research hospital providing specialized neurological, neurosurgical, cardiological, and rehabilitative healthcare services, alongside translational neuroscience research. The institute delivers advanced diagnostics (3T MRI, PET-CT, Nuclear Medicine), inpatient and outpatient neurological care, neurorehabilitation, telemedicine, and clinical research through its hospital in Pozzilli and Neurobiotech research center in Caserta. It also operates continuing medical education programs and university partnerships with Sapienza and Tor Vergata.

Product overview

Istituto Neurologico Mediterraneo Neuromed (IRCCS Neuromed) is a specialized neurological research and care institute comprising a hospital facility in Pozzilli and the Neurobiotech research center in Caserta. The institution offers a comprehensive portfolio of neurological, neurosurgical, cardiological, and rehabilitative healthcare services alongside clinical research activities. Core offerings include the main hospital with multiple departments (Neurology, Neurosurgery, Neurorehabilitation, Stroke Unit), advanced diagnostic imaging services (3T MRI, PET-CT, Nuclear Medicine), neurophysiology diagnostics (EEG, EMG, ENG), and telemedicine consultations. The Neurobiotech center conducts Big Data-driven personalized medicine research. Educational services include ECM training courses, university partnerships, and AnatomyLab. The institute positions itself at the intersection of clinical care and translational research, with approximately 25,000 participants followed through the Moli-sani epidemiological study.

Differentiator

Problem solved

Functional benefit

Products and services

• IRCCS Neuromed Hospital (Pozzilli)
• Neurobiotech Research Center (Caserta)
• Radiology and Diagnostic Imaging
• Nuclear Medicine (PET-TC and Scintigraphy)
• Neurophysiopathology (EEG, EMG, ENG)
• Telemedicine in Neurology
• Neuromed Education and ECM Training
• PET-Amyloid for Alzheimer's Diagnosis
• PET-TC for Parkinson's Diagnosis
• Oncology Multidisciplinary Center
• Neuro-Ophthalmology and Rare Eye Diseases
• Center for Rare Diseases of the Nervous System and Sensory Organs
• Stroke Unit and Emergency Care
• Neuro-Rehabilitation

Quantifiable outcome

• 38% lower mortality risk in cancer survivors following healthy lifestyle habits
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

20 partnerships are on record, tiered core, major and minor.

• Associazione Italiana Epilessia (AIE)coreStrategic or Co-development Partner · 1 January 2025Protocollo d'intesa (memorandum of understanding) for a new model of care for epilepsy patients. Collaboration includes clinical care, research, international projects (including Guinea-Bissau), school education programs, and psychosocial support. The partnership inaugurated a dedicated epilepsy unit bearing the AIE logo.
• Fondazione Umberto Veronesi ETScoreStrategic or Co-development Partner · 1 January 2024Joint Research Platform (Piattaforma Congiunta) conducting the UMBERTO project on cardiovascular health and cancer survival. Combines Fondazione Veronesi's expertise with Neuromed's epidemiological research capabilities through the Moli-sani study.
• Università LUM Giuseppe DegennarocoreStrategic or Co-development PartnerCollaboration on Moli-sani study and Progetto UMBERTO. LUM professors serve as Principal Investigators and hold academic positions at Neuromed's Epidemiology and Prevention Unit.
• Sapienza Università di RomacoreStrategic or Co-development PartnerLong-standing research collaboration in neuroscience including neuropharmacology, neurobiology, and neurological disease research. Joint laboratories and research projects spanning diabetes effects on the brain, perineuronal nets, and neuropathic pain.
• Università di SalernomajorStrategic or Co-development PartnerCollaboration on Spirulina peptide research (SP6) for diabetes type 2 and vascular health. University of Salerno professors contribute pharmaceutical chemistry expertise.
• Università degli Studi di MilanomajorStrategic or Co-development PartnerJoint research on Huntington's disease studying how brain circuits alter in this neurodegenerative condition.
• Università di PisamajorStrategic or Co-development PartnerCollaboration on neurobiology of movement disorders research, including norepinephrine's protective effects on neurons and mechanisms of neurodegeneration.
• Università di Lund (Svezia)majorStrategic or Co-development PartnerInternational collaboration on stroke recovery research, specifically on mGlu5 receptors and brain plasticity in post-stroke rehabilitation.
• Università di Washington, St. Louis (USA)majorStrategic or Co-development PartnerInternational research partnership on stroke recovery and pharmacological treatment innovation through the mGlu5 receptor study.
• Università dell'Insubria (Varese)minorStrategic or Co-development PartnerAcademic partner in polypharmacy and epigenetic aging study contributing statistical and methodological expertise.
• Università Campus Bio-Medico di RomamajorStrategic or Co-development PartnerCollaboration on Alzheimer's disease research, specifically the role of midbrain degeneration in triggering inflammatory processes that accelerate the disease.
• Fondazione Santa Lucia I.R.C.C.S.majorStrategic or Co-development PartnerPartner institution in Alzheimer's disease research on midbrain degeneration and inflammatory mechanisms.
• Area Science Park (Trieste)minorOthersContributing partner in polypharmacy and epigenetic aging study based on Moli-sani project data.
• AGENAS - Agenzia Nazionale per i Servizi Sanitari RegionalicoreOthersGovernment agency curating the Programma Nazionale Esiti (PNE) which evaluates and ranks Italian healthcare facilities on clinical outcomes.
• Clinica Madrugada (Guinea-Bissau)minorStrategic or Co-development PartnerInternational epilepsy care project in one of the world's poorest countries. Neuromed specialists are establishing an epileptology outpatient clinic within the facility, with telemedicine support and local staff training.
• LILT (Lega Italiana per la Lotta contro i Tumori)minorGTM or Marketing PartnerPatient association ally in cancer prevention and support services.
• Associazione NeurofibromatosiminorGTM or Marketing PartnerPatient association partner for neurofibromatosis awareness and support.
• SonnomedminorGTM or Marketing PartnerSleep medicine association partner for awareness on sleep disorders.
• IRCCS Casa Sollievo della SofferenzaminorStrategic or Co-development PartnerResearch collaborator on the UMBERTO project studying cardiovascular health.
• Università Tor VergataminorStrategic or Co-development PartnerAcademic partner providing university degree courses (Corsi di Laurea) at Neuromed's educational facilities.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Fondazione IRCCS Istituto Neurologico Carlo Besta: Milan-based neurological IRCCS with national leadership in neurosurgery, neurology, and neuroscience research. Directly comparable as another Italian neurological specialty hospital with IRCCS status, research focus, and SSN-driven revenue model.
• IRCCS Fondazione Mondino: Pavia-based IRCCS specializing in neurology, neurorehabilitation, and child neuropsychiatry. A direct peer sharing the IRCCS designation, neurological specialty focus, and integrated clinical-research model.
• Fondazione Santa Lucia IRCCS: Rome-based IRCCS specializing in neurorehabilitation and neuroscience. A direct peer in neurological specialty hospital operations, neurorehabilitation services, and translational neuroscience research.

Broad incumbents

• IRCCS San Raffaele: Large multi-specialty research hospital in Milan with significant neuroscience and neurology programs. Comparable as a major Italian IRCCS but with broader service portfolio and significantly larger scale.
• IRCCS Ospedale San Raffaele Turro: Milan-based research hospital focused on neurology and rehabilitation. Operates in a similar neuroscience/rehabilitation space but as part of the larger San Raffaele hospital group.
• Humanitas Research Hospital: Rozzano (Milan) based multi-specialty teaching hospital with strong neuroscience and research programs. A broader incumbent operating in the same hospital market but with diversified specialty mix.
• Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals with major neurology and neuroscience departments. Comparable as a leading European neurology/neuroscience center combining clinical care, research, and education.
• Karolinska University Hospital: Stockholm-based academic medical center affiliated with Karolinska Institutet with leading neurology, neurosurgery, and neuroscience research. Comparable as a European neurology reference center with integrated research and clinical excellence.

Regional players

• IRCCS Casa Sollievo della Sofferenza: San Giovanni Rotondo-based IRCCS in southern Italy. Operates as a research hospital in southern Italy with overlapping research collaborations (e.g., UMBERTO project with Neuromed) and a comparable IRCCS-plus-public-system operating model.

Others

• Fondazione Telethon: Italian biomedical research foundation funding rare disease and genetic disease research. Comparable as a research-funding partner ecosystem player supporting Neuromed's rare neurological disease work through grants.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/neuromedirccs

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Istituto Neurologico Mediterraneo Neuromed